Many patients notice appetite suppression within the first week, but measurable weight loss on the scale usually emerges between weeks 4 and 12 as the body adapts and doses gradually increase
Pair these results with symptom tracking to stay on top of your progress and address any challenges
However, maintaining a calorie-deficient diet is also one of the hardest parts of following a medical weight loss program, as patients are encouraged to continue exercising and will experience increased hunger and cravings
By the third week, patients typically experience stronger appetite suppression and a noticeable change in their eating habits
If you are interested in partnering with a pharmacy that supports clinical curiosity, collaborative problem-solving, and evidence-informed discussion, we invite you to become a partner with Strive and access dedicated support that complements your care model
Melanotan II is a synthetic analog of the peptide hormone alpha-melanocyte-stimulating hormone (a-MSH) that stimulates melanogenesis